The Global Artificial Lungs Industry Analysis & Forecast Report 2016-2021 is a professional and in-depth study on the current state of the Artificial Lungs industry. The report analysis the global market of Artificial Lungs by main manufactures and geographic regions. The report includes Artificial Lungs definitions, product type, applications and industry chain structure, development trends, competitive landscape analysis, and key regions development and import/export status.


For main manufacturers, company profiles, product analysis, shipment, ASPs, revenue, market shares and contact information are included. For industry chain, upstream raw materials and equipment and downstream demand analysis are also carried out. Finally, global and major regions Artificial Lungs industry forecast is offered.


Timescal:
1. 2011-- 2016 base years
2. 5-year annual forecast (2017 - 2021)


Region and Country Coverage:
North America, China, Japan, Europe, South-Korea, Middle East and Rest of the World.


Major players Coverage:
Abbott Diabetes Care, Inc. (USA)
Baxter International, Inc. (USA)
Vital Therapies, Inc. (USA)
Xenios AG (Germany)
Asahi Kasei Medical Co., Ltd. (Japan)
Medtronic, Inc. (USA)
F.Hoffmann-La Roche Ltd. (Switzerland)
Fresenius Medical Care AG & Co. KGaA (Germany)
HeartWare International, Inc. (USA)
Jarvik Heart, Inc. (USA)
Nikkiso Co., Ltd. (Japan)
Nipro Corporation (Japan)
SynCardia Systems, Inc. (USA)
Terumo Heart, Inc. (USA)
Thoratec Corp. (USA)
Toray Medical Co., Ltd. (Japan)


Key Issues Addressed
1. Competitive Landscape and Strategic Recommendations
2. The market forecast and growth areas for Artificial Lungs Industry
3. Changing Market Trends and Emerging Opportunities
4. Historical shipment and revenue
5. Analysis key applications
6. Main manufacturers market share


Customization
We can offer customization in the report without any extra charges and get research data or trends added in the report as per the buyer’s specific needs.